Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $2.09 Analyst target: $3.50 Upside: 67.46%
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing and acquiring non-invasive technologies for the treatment of symptoms caused by neurological diseases or trauma. The company is headquartered in Newtown, Pennsylvania.
See the full interactive analysis & chart →Informational only — not investment advice.